(Q26765999)

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Coding mutations in SORL1 and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau gene mutations and their effects.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Alzheimer's pathogenesis: is there neuron-to-neuron propagation?

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Epitopes that span the tau molecule are shared with paired helical filaments.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The carboxyl third of tau is tightly bound to paired helical filaments.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

γ-Secretase modulators: current status and future directions

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

γ-Secretase inhibitors and modulators

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Alzheimer mechanisms and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Emerging biomarkers in cognition

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

RAGE and TLRs: relatives, friends or neighbours?

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A network approach to clinical intervention in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Identification of Alzheimer disease-associated variants in genes that regulate retromer function

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Missense variant in TREML2 protects against Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Propagation of tau pathology in a model of early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Biomarker modeling of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The propagation of prion-like protein inclusions in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Will anti-amyloid therapies work for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Preparation and characterization of neurotoxic tau oligomers

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Synergistic interactions between repeats in tau protein and Aβ amyloids may be responsible for accelerated aggregation via polymorphic states

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Development and mechanism of γ-secretase modulators for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Divergent Synthesis of Multifunctional Molecular Probes To Elucidate the Enzyme Specificity of Dipeptidic γ-Secretase Inhibitors

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

BACE1 regulates voltage-gated sodium channels and neuronal activity

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Transmission and spreading of tauopathy in transgenic mouse brain

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Reconstitution of gamma-secretase activity

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Pharmacological chaperones stabilize retromer to limit APP processing

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Combating neurodegenerative disease with chemical probes and model systems

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Prion-like transmission of protein aggregates in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Prion-like mechanisms in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Cell-to-cell transmission of non-prion protein aggregates.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Neuroimaging biomarkers of neurodegenerative diseases and dementia

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Some Speculations about Prions, Amyloid, and Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A phase 3 trial of semagacestat for treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

TREM2 Variants in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau is essential to beta -amyloid-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Structural investigation of the C-terminal catalytic fragment of presenilin 1

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Purified and synthetic Alzheimer's amyloid beta (Aβ) prions

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Allosteric regulation of γ-secretase activity by a phenylimidazole-type γ-secretase modulator

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A protein factor essential for microtubule assembly

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A nucleated assembly mechanism of Alzheimer paired helical filaments

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Phosphorylation of tau is regulated by PKN.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau aggregation and toxicity in a cell culture model of tauopathy

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Propagation of tau misfolding from the outside to the inside of a cell.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Molecular genetics of Alzheimer's disease: an update

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Neuropathological alterations in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Transgenic mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Control of peripheral nerve myelination by the beta-secretase BACE1

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau reduction prevents Abeta-induced defects in axonal transport.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Cell biology. A unifying role for prions in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Novel proteinaceous infectious particles cause scrapie

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Neurodegenerative tauopathies

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Role of tau protein in both physiological and pathological conditions.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Genetics of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Posterior cortical atrophy: evidence for discrete syndromes of early-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Genetic variation at CR1 increases risk of cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The retromer complex - endosomal protein recycling and beyond

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Trans-synaptic spread of tau pathology in vivo

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Regulation of amyloid precursor protein processing by serotonin signaling

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The Y-Box Binding Protein 1 Suppresses Alzheimer's Disease Progression in Two Animal Models

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Targeting tau protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Vaccination with peptide 173-193 of acetylcholine receptor α7-subunit prevents memory loss in olfactory bulbectomized mice

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Immunotherapy for Alzheimer's disease: past, present and future

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

Alzheimer disease: a tale of two prions

1 reference

https://api.crossref.org/works/10.1134%2FS000629791513012X

7 January 2021

10.1134/S000629791513012X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

4249738

1038729785

0 references

Fatcat ID

release_ts4jf3s6rnfmtiomcd4xtcavx4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ts4jf3s6rnfmtiomcd4xtcavx4

24 November 2022

mapped directly with Wikidata item

4249738

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference